Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

24.78
BATS BZX Real-Time Price
As of 2:19pm ET
 -0.43 / -1.71%
Today’s Change
14.03
Today|||52-Week Range
34.79
-20.40%
Year-to-Date
3 Bold Bets on the Future of Biotechnology
Sep 25 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close25.21
Today’s open24.74
Day’s range24.56 - 25.24
Volume33,815
Average volume (3 months)768,753
Market cap$1.3B
Dividend yield--
Data as of 2:19pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-15.47%
Earnings growth (this year)-26.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.47%
P/E ratioNM
Price/Sales49.66
Price/Book9.43

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.29-1.25%
SUPNSupernus Pharmaceuti...-0.24-0.92%
INVAInnoviva Inc-0.29-2.53%
TXMDTherapeuticsMD Inc+0.22+3.43%
Data as of 2:18pm ET, 09/26/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$27.3M
Annual profit (last year)-$91.1M
Net profit margin-333.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Prabhavathi B. Fernandes
Chief Financial Officer &
Executive Vice President
Mark W. Hahn
Corporate headquarters
Chapel Hill, North Carolina

Forecasts

Search for Jobs